This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (ISICA-13)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Andreas Sonesson, Region Skane
ClinicalTrials.gov Identifier:
NCT01953380
First received: September 20, 2013
Last updated: April 11, 2017
Last verified: April 2017
  Purpose
The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Condition Intervention
Dermatitis, Allergic Contact Behavioral: extended information

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Outcomes Assessor
Primary Purpose: Prevention
Official Title: Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Resource links provided by NLM:


Further study details as provided by Andreas Sonesson, Region Skane:

Primary Outcome Measures:
  • knowledge [ Time Frame: one year after inclusion ]
    knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.


Secondary Outcome Measures:
  • clinical improvement [ Time Frame: one year after inclusion ]
    assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

  • quality of life [ Time Frame: one year after inclusion ]
    assessed by questionnaire, Dermatology Life Quality Index (DLQI).

  • effect on daily functioning [ Time Frame: one year after inclusion ]
    assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).


Enrollment: 400
Study Start Date: October 2013
Study Completion Date: September 2016
Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: extended information
Extended information on specific allergy
Behavioral: extended information
No Intervention: Information according to clin. routine
Information according to clinical routine

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with suspected contact allergy
  • Age above 18 years
  • Participants have given informed consent

Exclusion Criteria:

  • Mental or language disabilities
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01953380

Locations
Sweden
Hudmottagningen SUS
Lund, Skåne, Sweden, 22185
Sponsors and Collaborators
Region Skane
Investigators
Principal Investigator: Andreas Sonesson, MD PhD Region Skåne, Hudkliniken SUS
  More Information

Responsible Party: Andreas Sonesson, MD PhD, Region Skane
ClinicalTrials.gov Identifier: NCT01953380     History of Changes
Other Study ID Numbers: ISICA-13
Study First Received: September 20, 2013
Last Updated: April 11, 2017

Keywords provided by Andreas Sonesson, Region Skane:
Intervention Studies
Eczema
Randomized Controlled Trial
Knowledge
Quality of Life

Additional relevant MeSH terms:
Dermatitis
Dermatitis, Allergic Contact
Skin Diseases
Dermatitis, Contact
Skin Diseases, Eczematous
Hypersensitivity, Delayed
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on June 23, 2017